MANA Advisors LLC bought a new stake in shares of Petmed Express Inc (NASDAQ:PETS) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 5,114 shares of the company’s stock, valued at approximately $233,000.
Other large investors have also recently added to or reduced their stakes in the company. Royal Bank of Canada increased its position in Petmed Express by 86.5% during the 2nd quarter. Royal Bank of Canada now owns 8,337 shares of the company’s stock valued at $338,000 after purchasing an additional 3,867 shares during the period. Schwab Charles Investment Management Inc. boosted its holdings in shares of Petmed Express by 4.9% during the 3rd quarter. Schwab Charles Investment Management Inc. now owns 88,959 shares of the company’s stock worth $2,949,000 after buying an additional 4,195 shares in the last quarter. Prudential Financial Inc. boosted its holdings in shares of Petmed Express by 552.8% during the 3rd quarter. Prudential Financial Inc. now owns 824,434 shares of the company’s stock worth $27,330,000 after buying an additional 698,140 shares in the last quarter. Verity Asset Management Inc. bought a new position in shares of Petmed Express during the 4th quarter worth approximately $274,000. Finally, Municipal Employees Retirement System of Michigan boosted its holdings in shares of Petmed Express by 20.5% during the 3rd quarter. Municipal Employees Retirement System of Michigan now owns 16,830 shares of the company’s stock worth $558,000 after buying an additional 2,860 shares in the last quarter. 91.30% of the stock is owned by institutional investors and hedge funds.
In related news, Director Gian Fulgoni sold 20,000 shares of the stock in a transaction on Friday, December 15th. The stock was sold at an average price of $44.38, for a total value of $887,600.00. Following the transaction, the director now directly owns 55,900 shares in the company, valued at approximately $2,480,842. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Ronald J. Korn sold 5,000 shares of the stock in a transaction on Monday, January 29th. The stock was sold at an average price of $48.38, for a total value of $241,900.00. Following the completion of the transaction, the director now owns 68,833 shares in the company, valued at $3,330,140.54. The disclosure for this sale can be found here. Over the last quarter, insiders sold 65,000 shares of company stock worth $3,229,500. 4.00% of the stock is owned by company insiders.
Petmed Express (NASDAQ:PETS) last issued its earnings results on Monday, January 22nd. The company reported $0.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.33 by $0.11. Petmed Express had a return on equity of 34.04% and a net margin of 12.84%. The company had revenue of $60.10 million for the quarter, compared to analysts’ expectations of $56.76 million. During the same period last year, the business earned $0.24 EPS. Petmed Express’s quarterly revenue was up 13.6% compared to the same quarter last year. equities analysts forecast that Petmed Express Inc will post 1.77 EPS for the current year.
The company also recently announced a quarterly dividend, which was paid on Friday, February 16th. Investors of record on Monday, February 5th were issued a $0.25 dividend. This is a boost from Petmed Express’s previous quarterly dividend of $0.20. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.14%. The ex-dividend date was Friday, February 2nd. Petmed Express’s dividend payout ratio (DPR) is currently 59.17%.
A number of research firms have issued reports on PETS. ValuEngine cut Petmed Express from a “buy” rating to a “hold” rating in a report on Friday, February 23rd. Northcoast Research set a $58.00 price target on Petmed Express and gave the stock a “buy” rating in a report on Wednesday, January 3rd. Finally, BidaskClub cut Petmed Express from a “strong-buy” rating to a “buy” rating in a report on Friday, January 19th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and three have issued a buy rating to the company. Petmed Express presently has a consensus rating of “Hold” and an average price target of $42.80.
TRADEMARK VIOLATION NOTICE: This piece was first posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international trademark & copyright law. The original version of this piece can be accessed at https://www.tickerreport.com/banking-finance/3261549/mana-advisors-llc-buys-shares-of-5114-petmed-express-inc-pets.html.
Petmed Express Company Profile
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Want to see what other hedge funds are holding PETS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Petmed Express Inc (NASDAQ:PETS).
Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.